1. Home
  2. ANDE vs AUPH Comparison

ANDE vs AUPH Comparison

Compare ANDE & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$70.65

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.18

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANDE
AUPH
Founded
1947
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
ANDE
AUPH
Price
$70.65
$16.18
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$75.00
$17.25
AVG Volume (30 Days)
348.0K
924.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
1.03%
N/A
EPS Growth
N/A
5075.00
EPS
2.62
0.53
Revenue
$11,008,928,000.00
$283,055,000.00
Revenue This Year
$7.28
$17.54
Revenue Next Year
$3.57
$15.74
P/E Ratio
$26.45
$30.34
Revenue Growth
N/A
20.38
52 Week Low
$37.69
$10.34
52 Week High
$82.11
$19.25

Technical Indicators

Market Signals
Indicator
ANDE
AUPH
Relative Strength Index (RSI) 57.01 52.13
Support Level $68.57 $14.61
Resistance Level $71.18 $16.46
Average True Range (ATR) 2.44 0.47
MACD 0.76 -0.03
Stochastic Oscillator 95.83 33.54

Price Performance

Historical Comparison
ANDE
AUPH

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: